Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sedentary Behavior 1Pain 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Insulin Resistance 1Hyperlipidemias 1Hyperglycemia 1Hematologic Neoplasms 1Delirium 1Advanced Cancer 1

Interventions

Acupuncture Therapy 12Analgesia 11Therapeutics 8Psychiatric Rehabilitation 6Music Therapy 6Early Intervention, Educational 6Yoga 5Surveys and Questionnaires 5Water 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Morphine 4Methods 4Control Groups 4Colonoscopy 4Bupivacaine 4Aromatherapy 4Touch 3Standard of Care 3Saline Solution 3Physical Therapy Modalities 3Mindfulness-Based Stress Reduction 3Methadone 3Meditation 3Massage 3Exercise 3Electroacupuncture 3Cryotherapy 3Art Therapy 3Zoledronic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pain × Olanzapine × Clear all
NCT00737191 2012-03-09

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Mayo Clinic

Phase NA Withdrawn
Other hematologic neoplasm

Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡